Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

I used to spend about 60% of each day thinking about food—when was the next meal? What was I going to eat? Would it be ...

To Alabama football quarterback Ty Simpson, the Crimson Tide's 23-21 regular-season loss to Oklahoma was nothing different ...

A GP says she has experienced patients putting "weights on their backs" to falsify readings in order to be prescribed ...

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...

Tirzepatide starts working quickly. You might notice less hunger in a few days or weeks. Average weight loss in 3 weeks is ...

Research suggests certain medications could help build or maintain muscle during weight loss. Here's how they work & how to ...

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

In the ATTAIN-MAINTAIN study of its orforglipron candidate, switching to the drug after 72 months of injectable treatment ...

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.